Doctors Note Logo

Published on: 9/13/2026

What are the signs of dangerous internal bleeding on Eliquis?

Signs of dangerous internal bleeding while taking Eliquis (apixaban) include red, pink, or brown urine, black or tarry stools, vomiting blood or material that looks like coffee grounds, coughing up blood, and unusual bruising or swelling. Bleeding in the brain may cause sudden severe headache, confusion, vision changes, weakness, or trouble speaking, while unexplained dizziness, fainting, extreme fatigue, shortness of breath, or abdominal or joint pain can signal hidden blood loss. Any bleeding that will not stop after 10 minutes of pressure, or that follows a fall or head injury, needs emergency evaluation even if you feel fine. Several factors change your risk, including your dose, kidney function, age, and other medications such as NSAIDs or aspirin, so see below to understand more.

If you are noticing symptoms that could point to bleeding, guessing is the riskiest option, since internal bleeding on a blood thinner can worsen quickly and quietly. Take a free, instant, online symptom check to help clarify what your symptoms may mean and decide whether to call your prescriber or seek urgent care now.

Last reviewed for medical accuracy: 09/12/2026

answer background

Explanation

Understanding Eliquis and the Risk of Internal Bleeding

Eliquis (apixaban) is a widely prescribed blood thinner used to reduce the risk of stroke and blood clots in conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. As with any anticoagulant, Eliquis side effects can include bleeding. Most bleeding is minor—like easy bruising or nosebleeds—but on rare occasions, internal bleeding can be serious or life threatening. Recognizing early warning signs and seeking prompt care can make all the difference.


Why Internal Bleeding Can Be Dangerous

Blood thinners work by interfering with your body’s ability to form clots. While this prevents harmful clots, it also raises the risk that bleeding won’t stop on its own. Internal bleeding isn’t always obvious. It can develop gradually or suddenly, depending on the location and cause. Untreated, significant blood loss can lead to:

  • A drop in blood pressure
  • Organ damage
  • Shock or loss of consciousness

Early detection and treatment help prevent complications.


Common Signs of Dangerous Internal Bleeding on Eliquis

Below are warning signs you should never ignore. If you experience any of these, seek medical attention immediately.

1. Gastrointestinal Bleeding

Bleeding in the stomach or intestines may cause:

  • Black, tarry stools (melena)
  • Bright red blood in stool
  • Coffee-ground vomit (dark, grainy material)
  • Stomach cramps or persistent abdominal pain
  • Unexplained weakness or lightheadedness

2. Intracranial (Brain) Bleeding

Although rare, bleeding in or around the brain is a medical emergency. Watch for:

  • Severe headache that comes on suddenly
  • Vision changes, such as blurred or double vision
  • Sudden confusion or difficulty speaking
  • Weakness or numbness on one side of the body
  • Seizures or loss of consciousness

3. Genitourinary (Kidneys, Bladder) Bleeding

Blood in the urine or around reproductive organs can signal bleeding:

  • Pink, red, or cola-colored urine
  • Painful urination or burning sensation
  • Unusual vaginal bleeding or heavy periods
  • Sharp pain in the flank (side of the lower back)

4. Muscle, Joint, or Soft-Tissue Bleeding

Bleeding into muscles or joints may show up as:

  • Severe, unexplained swelling in an arm or leg
  • Intense joint pain with limited range of motion
  • Hard, painful lumps under the skin
  • Persistent soreness after minimal injury

5. Pulmonary (Lung) Bleeding

Blood in the lungs can be life threatening. Look for:

  • Coughing up blood (bright red or pink-tinged)
  • Difficulty breathing or shortness of breath
  • Chest pain that worsens with breathing or coughing
  • Rapid breathing or a feeling of air hunger

General Warning Signs of Significant Blood Loss

In addition to site-specific symptoms, these general signs may indicate serious bleeding:

  • Rapid heart rate (tachycardia)
  • Low blood pressure (dizziness, fainting)
  • Cold, clammy skin
  • Excessive fatigue or sudden weakness
  • Lightheadedness or feeling faint

If you notice a combination of these symptoms, treat it as an emergency.


What to Do If You Suspect Dangerous Bleeding

  1. Stop any activity and rest.
  2. Call emergency services (for sudden, severe symptoms) or have someone drive you to the closest emergency department.
  3. Contact your prescribing doctor or anticoagulation clinic—describe your symptoms in detail.
  4. Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
  5. Keep a record of when symptoms started, how long they’ve lasted, and any medications or supplements you’ve taken.

Sharing clear information helps your care team respond quickly and effectively.


Preventing Serious Bleeding While on Eliquis

While you can’t eliminate all risk, these steps reduce your chance of dangerous bleeding:

  • Take Eliquis exactly as prescribed—never skip or double doses.
  • Inform every healthcare provider (dentist, surgeon, physical therapist) that you’re on Eliquis.
  • Use a soft-bristle toothbrush and electric razor to minimize cuts and gum bleeds.
  • Avoid activities with high risk of falls or injury (contact sports, heavy machinery).
  • Be cautious with other medications or supplements that increase bleeding risk (NSAIDs, certain herbal products).

When to Speak to a Doctor

Some bleeding may appear minor but can mask something serious. Always reach out if you notice:

  • Any blood in stool, urine, or vomit
  • Unusual or heavy bruising
  • New, severe aches or pains without clear cause
  • Dizziness or fainting spells

For concerns that feel urgent—but not yet life threatening—you can also try a free, online symptom check, using the doctor approved Ubie Symptom Checker to guide your next steps.


Key Takeaways

  • Eliquis is effective at preventing clots but carries a risk of bleeding, one of the most serious Eliquis side effects.
  • Dangerous internal bleeding can occur in the gut, brain, lungs, muscles, joints, and urinary tract.
  • Know the warning signs—black stools, sudden headaches, coughing up blood, rapid heart rate—and act fast.
  • Prevention includes strict adherence to your dosage, avoiding high-risk activities, and being mindful of other medications.
  • If you suspect significant bleeding, seek emergency care and speak to your doctor right away.

Your health matters. Never hesitate to seek help for bleeding that feels out of the ordinary or severe. Always speak to a doctor about anything life threatening or serious.

(References)

  • * Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L, ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27. PMID: 21870978.

  • * Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A, Raskob GE, Weitz JI, AMPLIFY-EXT Investigators. Apixaban for extended treatment of venous thromboembolism. N Engl J Med. 2013 Feb 21;368(8):699-708. doi: 10.1056/NEJMoa1207541. Epub 2012 Dec 8. PMID: 23216615.

  • * Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI, AMPLIFY Investigators. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013 Aug 29;369(9):799-808. doi: 10.1056/NEJMoa1302507. Epub 2013 Jul 1. PMID: 23808982.

  • * Kuno T, Takagi H, Ando T, Sugiyama T, Miyashita S, Valentin N, Shimada YJ, Kodaira M, Numasawa Y, Briasoulis A, Burger A, Bangalore S. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis. J Am Coll Cardiol. 2020 Jan 28;75(3):273-285. doi: 10.1016/j.jacc.2019.10.059. PMID: 31976865.

  • * Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M, Caravaggio Investigators. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer. N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29. PMID: 32223112.

  • * Mamas MA, Batson S, Pollock KG, Grundy S, Matthew A, Chapman C, Manuel JA, Farooqui U, Mitchell SA. Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial Fibrillation. Am J Cardiol. 2022 Mar 1;166:58-64. doi: 10.1016/j.amjcard.2021.11.021. Epub 2021 Dec 20. PMID: 34949473.

  • * Pokorney SD, Chertow GM, Al-Khalidi HR, Gallup D, Dignacco P, Mussina K, Bansal N, Gadegbeku CA, Garcia DA, Garonzik S, Lopes RD, Mahaffey KW, Matsuda K, Middleton JP, Rymer JA, Sands GH, Thadhani R, Thomas KL, Washam JB, Winkelmayer WC, Granger CB, RENAL-AF Investigators. Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial. Circulation. 2022 Dec 6;146(23):1735-1745. doi: 10.1161/CIRCULATIONAHA.121.054990. Epub 2022 Nov 6. PMID: 36335914.

  • * Payne RM, Burns KM, Glatz AC, Male C, Donti A, Brandão LR, Balling G, VanderPluym CJ, Bu'Lock F, Kochilas LK, Stiller B, Cnota JF 2nd, Rahkonen O, Khan A, Adorisio R, Stoica S, May L, Burns JC, Saraiva JFK, McHugh KE, Kim JS, Rubio A, Chía-Vazquez NG, Meador MR, Dyme JL, Reedy AM, Ajavon-Hartmann T, Jarugula P, Carlson-Taneja LE, Mills D, Wheaton O, Monagle P. Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease. J Am Coll Cardiol. 2023 Dec 12;82(24):2296-2309. doi: 10.1016/j.jacc.2023.10.010. PMID: 38057072.

  • * Piccini JP, Patel MR, Steffel J, Ferdinand K, Van Gelder IC, Russo AM, Ma CS, Goodman SG, Oldgren J, Hammett C, Lopes RD, Akao M, De Caterina R, Kirchhof P, Gorog DA, Hemels M, Rienstra M, Jones WS, Harrington J, Lip GYH, Ellis SJ, Rockhold FW, Neumann C, Alexander JH, Viethen T, Hung J, Coppolecchia R, Mundl H, Caso V, OCEANIC-AF Steering Committee and Investigators. Asundexian versus Apixaban in Patients with Atrial Fibrillation. N Engl J Med. 2025 Jan 2;392(1):23-32. doi: 10.1056/NEJMoa2407105. Epub 2024 Sep 1. PMID: 39225267.

  • * Castellucci LA, Chen VM, Kovacs MJ, Lazo-Langner A, Greenstreet P, Kahn S, Côté B, Schulman S, de Wit K, Douketis J, Suryanarayan D, Wan T, Yeo E, Le Templier G, Tran HA, Willcox A, Crowther HJ, Prasad R, Shivakumar S, Umana E, Ni Ainle F, Tritschler T, Barco S, Galanaud JP, Blondon M, Baumann Kreuziger L, Solymoss S, Kearon C, Thomas E, Ramsay T, Le Gal G, Rodger M, COBRRA Trial Investigators. Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism. N Engl J Med. 2026 Mar 12;394(11):1051-1060. doi: 10.1056/NEJMoa2510703. PMID: 41812192.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.